Tag: ImmunoOncology
Agenus Inventory: Immuno-Oncology Developments Amidst Fiscal Pressures (NASDAQ:AGEN)
Promising Outcomes for Non-MSI-H CRC Sufferers with New Combo RemedyThe combo, introduced on the ESMO-GI World Congress in June 2023, heralded substantial developments for 3L+ non-MSI-H CRC sufferers missing lively liver metastases....
Latest articles
Sign up to receive news and updates
To be updated with all the latest news, offers and special announcements.